Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Strong Buy

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Nuvalent, Inc. Class A Common Stock (NUVL)

Pharmaceutical Preparations

https://www.nuvalent.com

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

ONE BROADWAY, 14TH FLOOR
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/29/2021

Market Cap

4,581,190,320

Shares Outstanding

57,200,000

Weighted SO

62,630,095

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

DICE --.--%

ACLX --.--%

PCVX --.--%

VRDN --.--%

VTYX --.--%

CGEM --.--%

KNSA --.--%

REPL --.--%

Beta

1.2820

Last Div

0.0000

Range

39.86-89.39

Chg

-1.2100

Avg Vol

362675

Mkt Cap

4581190320

Exch

NASDAQ

Country

US

Phone

857 357 7000

DCF Diff

66.1497

DCF

5.7604

Div Yield

0.0000

P/S

0.0000

EV Multiple

-22.1893

P/FV

7.1701

Div Yield %

0.0000

P/E

-26.3133

PEG

0.5644

Payout

0.0000

Current Ratio

17.4450

Quick Ratio

17.4450

Cash Ratio

2.0345

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0280

ROA

-0.2571

ROE

-0.2883

ROCE

-0.3186

NI/EBT

1.0032

EBT/EBIT

0.8526

EBIT/Rev

0.0000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-5.0788

CF/Debt

0.0000

Equity Multi

1.0600

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-2.0190

FCF/Share

-2.0190

Cash/Share

10.1848

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

7.1701

P/B

7.1701

P/S

0.0000

P/E

-26.3133

P/FCF

-35.1219

P/OCF

-35.0176

P/CF

-35.0176

PEG

0.5644

P/S

0.0000

EV Multiple

-22.1893

P/FV

7.1701

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation